Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma

American Journal of Transplantation

Volumn 2, Issue 8, 2002, Pages 774-779

  Sudan, Debra ^a   DeRoover, Arnaud ^a   Chinnakotla, Srinath ^a   Fox, Ira ^a   Shaw Jr , Byers ^a   McCashland, Tim ^b   Sorrell, Mike ^b   Tempero, Margaret ^a   Langnas, Alan ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Adjavant therapy; Cholangiocarcinoma; Liver transplantation; Radiochemotherapy

Indexed keywords

FLUOROURACIL; IRIDIUM 192;

ABDOMINAL PAIN; ADULT; ARTERY THROMBOSIS; ARTICLE; BACTERIAL PERITONITIS; BILE DUCT CARCINOMA; BRACHYTHERAPY; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL ARTICLE; FEMALE; GASTRITIS; GRAFT FAILURE; GRAFT REJECTION; HEPATIC ARTERY; HUMAN; LIVER HILUS; LIVER TRANSPLANTATION; MALE; METASTASIS; MYCOSIS; SEPSIS;

ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CHOLANGITIS; FEMALE; FLUOROURACIL; HUMANS; IRIDIUM RADIOISOTOPES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RADIOTHERAPY; TREATMENT OUTCOME;

EID: 0036766649     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2002.20812.x     Document Type: Article

References (26)

1. Ahrendt SA, Cameron JL, Pitt HA. Current management of patients with perihilar cholangiocarcinoma. Adv Surg 1996; 30: 427-52.
2. Bass NM. Sclerosing cholangitis and recurrent pyogenic cholangitis. In: Feldman M, Scharschmidt BF, Sleisenger MG (eds.) Gastrointestinal and Liver Disease. Philadelphia: Saunders, 1998, 1006.
3. Rosen CB, Nagorney DM, Wiesner RH, Coffey RJ Jr, LaRusso NF. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 1991; 213: 21-25.
4. Pitt HA, Dooley WC, Yeo CJ, Cameron JL. Malignancies of the biliary tree. Curr Probl Surg 1995; 32: 1-90.
5. Lee CK, Barrios BR, Bjamason H. Biliary tree malignancies, the University of Minnesota experience. J Surg Oncol 1997; 65: 298-305.
6. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001; 33: 1353-1357.
7. Urego M, Flickinger JC, Carr BI. Radiotherapy and multimodality management of cholangiocarcinoma. Int J Radiat Oncol Biol Phys 1999; 44: 121-126.
8. Cameron JL, Pitt HA, Zinner MJ, Kaufman SL, Coleman J. Management of proximal cholangiocarcinomas by surgical resection and radiotherapy. Am J Surg 1990; 159: 91-97; discussion 97-8.
9. Pichlmayr R, Weimann A, Klempnauer J et al. Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg 1996; 224: 628-638.
10. Hadjis NS, Blenkharn JI, Alexander N, Benjamin IS, Blumgart LH. Outcome of radical surgery in hilar cholangiocarcinoma. Surgery 1990; 107: 597-604.
11. Klempnauer J, Ridder GJ, Werner M, Weimann A, Pichlmayr R. What constitutes long-term survival after surgery for hilar cholangiocarcinoma? Cancer 1997; 79: 26-34.
12. Nakeeb A, Pitt HA, Sohn TA et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996; 224: 463-473; discussion 473-5.
13. Burke EC, Jarnagin WR, Hochwald SN, Pisters PW, Fong Y, Blumgart LH. Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg 1998; 228: 385-394.
14. McMasters KM, Tuttle TM, Leach SD et al. Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. Am J Surg 1997; 174: 605-608; discussion 608-9.
15. De Vreede I, Steers JL, Burch PA et al. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 2000; 6: 309-316.
16. Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992; 215: 31-38.
17. Iwatsuki S, Todo S, Marsh JW et al. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection transplantation. J Am Coll Surg 1998; 187: 358-364.
18. Pichlmayr R, Lamesch P, Weimann A, Tusch G, Ringe B. Surgical treatment of cholangiocellular carcinoma. World J Surg 1995; 19: 83-88.
19. Pitt HA, Nakeeb A, Abrams RA et al. Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival. Ann Surg 1995; 221: 788-797; discussion 797-8.
20. Curley SA, Levin B, Risch TA. Liver and bile ducts. In: Abeloff MD, Armitage JO, Lichter AS (eds.) Clinical Oncology. New York, NY: Churchill Livingstone, 1995: 1305.
21. Goldstein RM, Stone M, Tillery GW et al. Is liver transplantation indicated for cholangiocarcinoma? Am J Surg 1993; 166: 768-771; discussion 771-2.
22. Morganti AG, Trodella L, Valentini V et al. Combined modality treatment in unresectable extrahepatic biliary carcinoma. Int J Radiat Oncol Biol Phys 2000; 46: 913-919.
23. Fisher A, Theise ND, Min A et al. CA19-9 does not predict cholangiocarcinoma in patients with primary sclerosing cholangitis undergoing liver transplantation. Liver Transpl Surg 1995; 1: 94-98.
24. John TG, Greig JD, Crosbie JL, Miles WF, Garden OJ. Superior staging of liver tumors with laparoscopy and laparoscopic ultrasound. Ann Surg 1994; 220: 711-719.
25. Weber SM, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR. Staging laparoscopy in patients with extrahepatic biliary carcinoma analysis of 100 patients. Ann Surg 2002; 235: 392-399.
26. Read TE, McNevin MS, Gross EK et al. Neoadjuvant therapy for adenocarcinoma of the rectum: tumor response and acute toxicity. Dis Colon Rectum 2001; 44: 513-522.